BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9216013)

  • 21. Comparative investigations on the bioavailability of cefuroxime axetil.
    Kees F; Lukassek U; Naber KG; Grobecker H
    Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cefuroxime axetil in the sick elderly patient.
    Cowling P; Case CP; MacGowan AP; Lovering AM; Humphreys H; Reeves DS; Madan I; Harding M; Harvey JE
    J Antimicrob Chemother; 1992 Mar; 29(3):350-1. PubMed ID: 1592706
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of two types of Indian breakfast on bioavailability of cefuroxime axetil.
    Vasu S; Adithan C; Shashindran CH; Asad M; Koumaravelou K; Topno I
    Indian J Med Res; 2000 Sep; 112():104-8. PubMed ID: 11094856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraocular levels of cefuroxime in uninflamed rabbit eyes.
    Koul S; Philipson A; Philipson BT; Kock E; Nylén P
    Acta Ophthalmol (Copenh); 1990 Aug; 68(4):455-65. PubMed ID: 2220364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of cefuroxime and ceftazidime into human lungs.
    Perea EJ; Ayarra J; García Iglesias MC; García Luque I; Loscertales J
    Chemotherapy; 1988; 34(1):1-7. PubMed ID: 3280266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative bioavailability of cefuroxime axetil suspension formulations administered with food in healthy subjects.
    Mendes GD; Borges A; de Cássia Val L; Patni AK; Reyar S; Monif T; Sereno D; Orellana AM; De Nucci G
    Arzneimittelforschung; 2010; 60(2):101-5. PubMed ID: 20329659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery.
    Montan PG; Wejde G; Setterquist H; Rylander M; Zetterström C
    J Cataract Refract Surg; 2002 Jun; 28(6):982-7. PubMed ID: 12036640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
    Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlinear intestinal absorption kinetics of cefuroxime axetil in rats.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino M
    Antimicrob Agents Chemother; 1997 Feb; 41(2):445-8. PubMed ID: 9021205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of oral antimicrobial agent levels in tooth extraction sites.
    Yoshii T; Yoshikawa T; Furudoi S; Yoshioka A; Ohtsuka Y; Komori T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):643-8. PubMed ID: 11402275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefuroxime axetil].
    Matsumoto F; Oizumi K
    Jpn J Antibiot; 1988 Sep; 41(9):1181-93. PubMed ID: 3071614
    [No Abstract]   [Full Text] [Related]  

  • 32. Bioavailability of cefuroxime axetil formulations.
    Donn KH; James NC; Powell JR
    J Pharm Sci; 1994 Jun; 83(6):842-4. PubMed ID: 9120818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
    Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
    J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cefuroxime axetil in acute purulent exacerbations of chronic bronchitis.
    Davies BI; Maesen FP; Teengs JP
    Infection; 1987; 15(4):253-6. PubMed ID: 3312021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of cefuroxime into chronically inflamed sinus mucosa.
    Dinis PB; Monteiro MC; Lobato R; Martins ML; Gomes A
    Laryngoscope; 1999 Nov; 109(11):1841-7. PubMed ID: 10569419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
    Brink HS; Huisman RM; Geerlings W; de Jong PE
    Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preoperatively administered flomoxef sodium concentration in aqueous humor].
    Miyamoto M; Watanabe Y; Mizuki N
    Nippon Ganka Gakkai Zasshi; 2007 Apr; 111(4):326-30. PubMed ID: 17461038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penetration of cefuroxime into bronchial mucosa following oral administration of cefuroxime axetil.
    Winter J; Dhillon P
    J Antimicrob Chemother; 1991 Apr; 27(4):556-8. PubMed ID: 1856136
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function.
    Konishi K; Suzuki H; Hayashi M; Saruta T
    J Antimicrob Chemother; 1993 Mar; 31(3):413-20. PubMed ID: 8486575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intraocular penetration of cefuroxime after parenteral administration.
    Richards AB; Bron AJ; McLendon B; Kennedy MR; Walker SR
    Br J Ophthalmol; 1979 Oct; 63(10):687-9. PubMed ID: 508679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.